Faculty
Oncology Division
John F. DiPersio, MD, PhD
Virginia E. and Sam J. Golman Professor in Medicine
Chief, Division of Oncology
Director, Center for Gene and Cellular Immunotherapy
Deputy Director, Alvin J. Siteman Cancer Center
Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia
Stem Cell Biology
Department of Pediatrics
Department of Pathology & Immunology
Clinical Interests
- Allogeneic stem cell transplantation
- Haploidentical stem cell transplantation
Research Interests
- Hematopoietic growth factor receptors
- Murine models of graft-versus-host disease and graft-versus-leukemia
- Leukemia genomics
Contact
- 314-454-8306 (office)
- 314-454-7551 (fax)
- jdipersi@wustl.edu
- Division of Oncology
Mail Stop 8007-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - 11th Floor Mid-Campus Center (office)
- 626 Southwest Tower (lab)
- DiPersio lab website
Biosketch
| Education | |
|---|---|
| 1973 | BA in Biology (Magna Cum Laude), Williams College, Williamstown, MA |
| 1980 | MD/PhD in Microbiology, University of Rochester, Rochester, NY |
| Post-graduate Training | |
| 1980-1981 | Intern (Straight Medicine), Parkland Memorial Hospital, UT Southwestern, Dallas, TX |
| 1981-1983 | Resident, Parkland Memorial Hospital, UT Southwestern, Dallas, TX |
| 1983-1984 | Chief Resident, Parkland Memorial Hospital, UT Southwestern, Dallas, TX |
| 1984-1987 | Fellow, Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA |
| Academic Positions | |
| 1987-1988 | Instructor of Medicine, Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA |
| 1988-1990 | Assistant Professor of Medicine, Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA |
| 1990-1994 | Assistant Professor of Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY |
| 1990-1994 | Director, Bone Marrow Transplant Program, Strong Memorial Hospital, Rochester, NY |
| 1990-1994 | Assistant Professor of Medicine, Hematology Unit, University of Rochester School of Medicine, Rochester, NY |
| 1994-1997 | Associate Professor of Medicine, Pediatrics and Pathology, Washington University School of Medicine, St. Louis, MO |
| 1994-2000 | Chief, Division of Bone Marrow Transplantation & Stem Cell Biology, Washington University School of Medicine, St. Louis, MO |
| 1997-present | Professor of Medicine, Pediatrics and Pathology/Immunology, Washington University School of Medicine, St. Louis, MO |
| 1997-2000 | Acting Director, Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO |
| 2000-present | Deputy Director, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO |
| 2000-2006 | Director, Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, St. Louis, MO |
| 2000-present | Chief, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| 2006-2011 | Scientific Director, Good Manufacturing Procedure (GMP) Facility, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO |
| 2017-present | Director, Center for Gene and Cellular Immunotherapy (CGCI), Washington University School of Medicine, St. Louis, MO |
| Board Certification | |
| 1984 | American Board of Internal Medicine |
| 1987 | American Board of Internal Medicine (Medical Oncology) |
| 1988 | American Board of Internal Medicine (Hematology) |
| Other Experience & Professional Memberships | |
| 1993 | Member, Editorial Board, Journal of Experimental Hematology |
| 1995 | Member, Nominating Committee, International Society for Experimental Hematology |
| 1997 | Chairman, Nominating Committee, International Society for Experimental Hematology (ISEH) |
| 1997 | Member, Stem Cell Evaluation Committee, International Society for Hematotherapy and Graft Engineering (ISHAGE) |
| 1997 | Councilor, International Society of Experimental Hematology |
| 1998 | Member, Barnard Free Skin and Cancer Board of Directors |
| 1998 | Guest Editor, Blood Journal |
| 1999-2006 | Member, External Advisory Panel, M.D. Anderson, (MDACC) PPG-AML |
| 1999 | Deputy Director, Siteman Cancer Center, Washington University School of Medicine |
| 2000-2006 | Leukemia and Lymphoma Society of America, Career Development Award Study Section Member |
| 2000 | Chairman, NHLBI Consensus Conference on Allo Transplantation for Non-Malignant Diseases |
| 2002 | Member, Executive Committee IBMTR/ABMTR |
| 2003-2006 | Award Member, ASH Committee on Educational Affairs, Washington, DC |
| 2003-2006 | Member, Board of Directors, American Society of Biology and Marrow Transplant |
| 2004-2009 | NCI (NIH) Permanent member CONC Study Section Member |
| 2005 | Chairman, Study Section RFA HL-04-017 (NHLBI) Specialized Center for Cell Based Therapy |
| 2006 | NIH (ZRG)/CSR – Gene Therapy and Inborn Errors – Special Emphasis Review Panel |
| 2007-2012 | Co-Chair, CIBMTR Acute Leukemia Working Committee |
| 2008 | NCI P01 Special Emphasis Panel ZCA1-RPRB-J, October 2008, Bethesda MD |
| 2008 | ASH Scientific Committees on Cell and Gene Therapy and Hematopoiesis |
| 2008-2011 | Member, Scientific and Medical Research Funding; California Institute for Regenerative Medicine (CIRM) |
| 2009 | Member, Review Panel; Center Grants, National Medical Research Council, Singapore |
| 2009 | Member, ASBMT Committee on Research Priorities |
| 2010 | ASH/CRTI Faculty/Mentor |
| 2010 | Member, External Advisory Board, Cancer Therapy and Research Center, UT San Antonio |
| 2010 | Chairman, NIH NIAID ZAI1 MFH-01 P01 Special Emphasis Panel |
| 2011 | NIH (BST-M)/CSR- Special Emphasis Panel |
| 2011 | Study Section, Doris Duke Center Grants for Sickle Cell Disease |
| 2011 | Chairman, NIH/NIDDK P01 Special Emphasis Panel, Methylation and Hematopoiesis |
| 2012-2014 | Vice Chair (2012-13) and Chair (2013-14) ASH Scientific Committee on Hematopoiesis |
| 2012-present | NIH Study Section for Loan Repayment Program |
| 2012-present | EAB member, University of Michigan Cancer Center |
| 2013 | Member, NCI Provocative Questions B Study Section |
| 2013 | EAB member, Levine Cancer Institute |
| 2013-2019 | Member, Board of Scientific Councilors, National Cancer Institute (NCI) |
| 2014-2019 | Study Section Member CPRIT (Cancer Prevention Research Institute of Texas) |
| 2014 | CIRM Working Group 2.0 – Permanent Member |
| 2014-present | EAB member, University of Chicago |
| 2015 | American Cancer Society, National Board of Directors for Hope Lodges |
| 2015 | Medical Advisory Board, Gabrielle's Angel Foundation for Cancer Research |
| 2015-present | EAB member, Sylvester Comprehensive Cancer Center, University of Miami |
| 2015-2017 | Member, AACR-Aflac, Inc. Career Development Award for Pediatric Cancer Research Scientific Research Committee |
| 2016 | Chair, Data Safety Monitoring Committee (DSMC) BL-8040 and Nivolumb for the Treatment of Pancreatic Cancer |
| 2016 | Chair, DSMC Dana Farber/Boston Childrens Hospital "Use of Plerixafor for Stem Cell Mobilization in Patients with Sickle Cell Disease" |
| 2016-2019 | Member, AACR Science Policy and Government Affairs Committee (SPGAC) |
| 2017 | Review Committee Member, NIH Pioneer Award |
| 2017-2021 | Member, ASH Honorific Award and ASH Mentor Award Committee |
| 2017-2019 | Chair, for the Finneran Prize Awardee, MDACC |
| 2018 | Leukemia and Lymphoma Society New Idea Award Committee |
| 2018 | NIH/NCI Cancer Moonshot Human Tumor Atlas Study Section ZRG1 OTC-T |
| 2018 | EAB member, DFCI Leukemia SPORE |
| 2018-present | EAB member, University of Rochester |
| 2018-present | EAB member, Weill Cornell Medicine |
| 2018-present | Member AACR Honorific Awards Committee |
| 2019 | Member Scientific Committee, 2019 Acute Leukemias SVII, Munich Germany |
| 2019-present | Member Dana Farber Cancer Institute (DFCI) External Advisory Board |
| 2019-present | Member EAB of DFCI Leukemia SPORE |
| 2019-present | Member EAB of MSKCC Leukemia SPORE |
| 2020-present | Member EAB Mt. Sinai PPD in Stem Cell Transplantation |
| 2020-present | Member EAB O’Neal CCC at University of Alabama at Birmingham |
| 2020-present | Member EAB Case CCC |
| 2020-present | Member EAB DFCI Department of Medical Oncology |
| 2021 | City of Hope National Medical Center CCC EAB Member |
| Honors | |
| 1973 | BA, Magna Cum Laude, Honors in Biology, Williams College |
| 1980 | Alpha Omega Alpha, University of Rochester |
| 1986 | Special Fellow, Leukemia Society of America |
| 1989 | Junior Faculty Research Award, American Cancer Society |
| 1992 | Bauman Award - Teacher of the Year, Internal Medicine, University of Rochester |
| 1996 | Elected, American Society of Clinical Investigation (ASCI) |
| 1997 | Recipient, Lewis T. and Rosalind B. Apple Chair in Oncology |
| 2001 | ISHAGE Meeting, First prize, Scientific Merit: "Control of GvHD using genetically modified T cells" |
| 2008 | "Great Teacher" Lecture NIH |
| 2010 | Recipient, Virginia E. and Samuel J. Golman Endowed Professorship in Medicine |
| 2010 | Washington University Divisions of Hematology and Oncology "Teacher of the Year" |
| 2013 | Daniel P. Schuster Distinguished Translational Investigator Award, Washington University |
| 2013 | Member, Association of American Physicians (AAP) |
| 2014 | Recipient of AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research |
| 2014 | Thomson Reuters list of "Most Influential Scientific Minds" |
| 2014 | American Society of Hematology Mentor Award for Clinical Investigation |
| 2015 | Co-founder, Magenta Therapeutics, Cambridge, MA |
| 2016 | Washington University School of Medicine 2nd Century Award |
| 2016-2017 | Vice President/President-Elect, American Society of Blood and Marrow Transplantation |
| 2017 | Leukemia and Lymphoma Society of American Legacy Award |
| 2017-2024 | R35- NCI Outstanding Investigator Award “Optimizing Allogeneic HSCT” |
| 2018-2019 | President, American Society of Blood and Marrow Transplantation |
| 2018 | Karl Blume and Gerhard Schmidt Memorial Lecture, City of Hope Cancer Center, Duarte, CA |
| 2018 | Teacher of the Year, Department of Medicine, Washington University School of Medicine |
| 2018 | Founder, WUGEN Therapeutics, St. Louis, MO |
| 2019 | Thomas Buchner Memorial Lecture, Acute Leukemias XVII, Munich, Germany |
| 2019 | Distinguished Lecture Award, Society of Hematologic Oncology Annual Meeting |
| 2021 | AACR Co-Chair Annual Meeting, 2021 Program Committee |
| 2021 | Danny Thomas Lecture Award, St Jude Research Hospital, Memphis |
| 2021 | Fellow American Society of Transplantation and Cellular Therapy |
